Cystatin C compared to serum creatinine as a marker of acute kidney injury in critically ill neonates.
Eka Laksmi HidayatiMeita Dwi UtamiRinawati RohsiswatmoBambang TridjajaPublished in: Pediatric nephrology (Berlin, Germany) (2020)
CysC may be used as a screening biomarker of AKI in critically ill neonates; yet, it was not superior to serum creatinine. Graphical abstract.